Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M2YX
|
|||
| Former ID |
DIB002933
|
|||
| Drug Name |
CIGB-228
|
|||
| Synonyms |
Therapeutic peptide subunit vaccine (E7 antigen, HPV), CIGB
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Human papillomavirus infection [ICD-11: 1A9Y; ICD-9: 078.1079.4] | Phase 1 | [1] | |
| Company |
Center for Genetic Engineering and Biotechnology
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human papillomavirus protein E7 (HPV E7) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial. ISRN Obstet Gynecol. 2011; 2011: 292951. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.